NPHS1 and diabetic kidney disease: Consistent with previous reports, rapamycin markedly mitigated albuminuria (Figure 4B), glomerular hypertrophy, podocyte loss, and nephrin redistribution in STZ-induced DKD mice (Figure 4, C, I, and J).